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An Unusual Cause of 
Recurrent Laryngeal Nerve 
Monitoring Failure during 
Parathyroidectomy
ABSTRACT
Intraoperative monitoring of the recurrent laryngeal nerve (RLN) during surgical dissection allows for real time identification 
and assessment of nerve function integrity. Since neuromuscular blockade interferes with electromyography, long-acting 
muscle relaxants cannot be used during anesthesia. We report a patient in whom monitoring of the RLN was unsuccessful 
because of prolonged muscle paralysis following the administration of succinylcholine, presumably due to a pseudocho-
linesterase deficiency.
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Introduction
Intraoperative monitoring of the recu-
rrent laryngeal nerve (RLN) with elec-
tromyography improves precision in 
identification of the RLN and provides 
immediate electromyographic feed-
back regarding its integrity during sur-
gical dissection. A method of intrao-
perative RLN monitoring involves the 
use of electrodes attached to the sur-
face of an endotracheal tube that are 
placed in contact with the vocal cords 
during tracheal intubation. (1) Since 
neuromuscular blockade interferes with 
electromyography, long-acting nonde-
polarizing muscle relaxants cannot be 
used when this type of monitoring is 
employed.  Rather, only succinylcholine 
is used to facilitate tracheal intubation. 
We report a patient in whom intrao-
perative monitoring of the RLN was 
unsuccessful because of unrecognized 
prolonged muscle paralysis following 
the administration of succinylcholine, 
presumably due to one of the variants 
of pseudocholinesterase (PsChE) defi-
ciency.
Case report
Permission for this single case was wai-
ved by the Mayo Clinic, Rochester MN, 
Institutional Review Board. A 53-year 
old, female (height: 170 cm, weight: 
64.9 kg, BMI: 22.4 kg/m2) with primary 
hyperparathyroidism was admitted for 
resection of parathyroid adenoma due 
to primary hyperparathyroidism (serum 
calcium 11.1 mg/dL and parathyroid 
hormone concentration 96 pg/mL with 
a focus of discordant sestamibi uptake 
in the left thyroid bed compatible with a 
parathyroid adenoma). Except for the 
history of nephrolithiasis she was in an 
excellent state of health and was taking 
no medications.  
Her preanesthetic evaluation was unre-
markable except for her report that she 
was “slow to recovery” from anesthesia 
following an inguinal hernia repair 15 
years ago. She was unable to give any 
specific information regarding adverse 
perioperative events during that sur-
gery. General anesthesia was induced 
with 150 mg propofol i.v. and 100 mcg 
fentanyl i.v. Endotracheal intubation 
was facilitated with 100 mg succinylcho-
line i.v. (during parathyroid surgery and 
after a single dose of succinylcholine 
we do not conduct routine monitoring 
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of neuromuscular blockade with perip-
heral nerve stimulator, because arms 
are tucked [ulnar nerve monitoring] and 
head is covered with drapes [orbicula-
ris oculi monitoring]). The endotrache-
al tube used was a 7.0 mm diameter 
Sheridan® tube (Mallinckrodt, Hudson, 
RCI) with the recording single channel 
surface laryngeal electrode (Dragon-
fly®, Neurovision Medical products, 
INC, Ventura, Ca, USA) attached circu-
larly 2 cm above the cuff with placement 
between the vocal cords. The Nerveäna 
Surgical Nerve Locator (Neurovision 
Medical products, INC, Ventura, Ca, 
USA) system was used to monitor 
laryngeal nerves.  After positioning for 
surgery with neck extension, the proper 
position of the electrodes in relation to 
the vocal cords was reconfirmed under 
visualization with direct laryngoscopy. 
Anesthesia was maintained with a com-
bination of a propofol infusion (120 g/
kg/min) and desflurane 2–4%.
Following neck incision, the carotid 
sheath and RLN were visually identi-
fied, and the Nerveäna proactive loca-
tor (an insulated spatula) was used to 
stimulate the left vagus and left RLN 
nerve in order to elicit an audible elec-
tromyographic (EMG) signal. The sur-
geon increased stimulation intensity 
amplitude gradually from 0.5 mA to the 
maximum allowable amplitude of 3.0 
mA. Stimulation signals were at preset 
settings of 4 Hz with 150 microsecond 
pulses. In this case direct stimulation 
failed to elicit any audible EMG signal 
even at the maximum amplitude, nor 
we obtained a visible compound action 
potential waveform (figure 1). Finally, 
there was no visual evidence of con-
traction of the posterior cricoarytenoid 
muscle.  Thus, nerve conduction integri-
ty could not be assessed with this moni-
tor.  Because the most frequent cause 
of a nonconducting signal is malposi-
tion of the surface electrodes in relation 
to vocal cords, the anesthesiologist 
again ensured proper placement of the 
surface electrodes against the vocal 
cords with direct laryngoscopic visual-
ization (McGRATH® Video Laryngos-
cope).  All monitoring system connec-
tions were re-inspected and appeared 
intact. The monitoring system continued 
to fail to detect nerve conduction and 
the parathyroidectomy continued wit-
hout the assistance of nerve monitoring 
utilizing standard direct visualization of 
RLN.  The surgery lasted 90 minutes, 
which included waiting time for intra-
operative parathyroid hormone (PTH) 
measurement, during which time the 
patient was kept asleep with propofol 
(25 g/kg/min). Desflurane was dis-
continued 30 minutes before the end 
of surgery. The total amount of analge-
sics administered during the surgery 
was 200 mcg fentanyl and 15 mg of 
ketorolac.  Intraoperative PTH concen-
tration fell to greater than 50% of base-
line levels and the patient was deemed 
cured.  After obtaining these results the 
propofol was discontinued. Blood pres-
sure increased from 110/75 mmHg to 
165/90 mmHg, and heart rate from 75 
bpm to 135 bpm. However, the patient 
did not move or show signs of respira-
tory effort. A peripheral nerve stimulator 
was placed on the ulnar nerve to assess 
muscle function, and using the train-
of-four (TOF) stimulation mode elicited 
only 1 faint twitch of adductor pollicis 
brevis muscle.  Tetanic stimulation at 50 
Hz showed a fade pattern of adductor 
pollicis brevis. This suggested general-
ized muscle paralysis in our patient 
who did not receive a nondepolarizing 
muscle relaxant. Therefore, in order to 
prevent awareness, 60 mg of propo-
fol was administered followed by a 
propofol infusion (45 g/kg/min).  After 
an additional 25 minutes, the patient 
regained only 2 faint TOF twitches. Over 
the next 45 minutes, she regained all 4 
TOF twitches and full muscle strength 
(5 seconds of sustained head lift). She 
was allowed to awaken and her trachea 
was extubated without further incident. 
Since this clinical picture was consis-
tent with PsChE deficiency, appropriate 
laboratory studies were obtained: total 
PsChE activity was 1681 U/L (normal, 
2550 – 6800 U/L) and dibucaine num-
ber was 83% (reference range 70-90% 
inhibition).
Discussion
We described a patient in whom intra-
operative monitoring of RLN was not 
possible due to prolonged muscle 
blockade following a single dose of 
succinylcholine, which was presum-
ably caused by slowed metabolism 
of succinylcholine due to PsChE defi-
ciency. Presence of the fade on the 
TOF stimulation after succinylcholine in 
our patient suggests a phase II block or 
desensitizing block, which is consistent 
with prolonged succinylcholine metab-
olism in patients with PsChE deficiency. 
(2,3)  In the presence of muscle paraly-
Figure 1.  Stimulation of recurrent laryngeal nerve with Nerveäna proactive 
locator elicited an EMG signal.  Typically, stimulation intensity amplitude 
is increased gradually from 0.5 mA to the maximum allowable amplitude of 
3.0 mA.  Absence of successful stimulus response to elicit a robust action 
potential (in a form of an EMG waveform) indicates either presence of a tech-
nical problem (vocal cords are not in contact with electrodes), accidentally 
transected nerve (surgical injury), or presence of muscle paralysis (use of 
nondepolarizing muscle relaxants or in our case, the use of succinylcholine 
in a patient with pseudocholinesterase deficiency).  
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sis, no response or a weak response 
would be unlikely to trigger the audible 
alarm on EMG monitoring device used 
on our patient.  
The inability to monitor the RLN with 
electromyography triggered initially a 
search for mechanical failure (i.e., mal-
position of the endotracheal tube elec-
trodes), but the cause was not eluci-
dated until the end of surgery when we 
noticed that the patient had profound 
muscle paralysis which was clinically 
consistent with PsChE deficiency. Use 
of peripheral nerve stimulator earlier 
during the case could have helped to 
diagnose the problem, but this was not 
done.  While we routinely use periph-
eral nerve stimulators in majority of our 
cases where non-depolarizing muscle 
relaxants are administered, these moni-
tors are not typically employed follow-
ing the administration of a single dose 
of succinylcholine to facilitate tracheal 
intubation and when no other muscle 
relaxants will be used. PsChE deficien-
cy, especially the homozygous type, is 
a relatively rare condition, and we did 
not consider it in differential diagnosis 
after we encountered problems in RLN 
monitoring in our patient.  
In our patient, the result of testing for 
the most common types of PsChE defi-
ciency (silent gene, and/or dibucaine 
resistant variant) rendered the precise 
diagnosis of the variant of PsChE defi-
ciency inconclusive. The patient’s total 
pseudocholinesterase activity was 35% 
below the lower limit of normal, and 
the dibucaine inhibition was normal. 
These tests excluded the most frequent 
mutations of the butyrylcholinesterase 
gene (gene responsible for PsChE defi-
ciency): homozygous A-variant [AA] or 
silent (S) mutation [SS], or a combina-
tion of an A-variant and a (S) mutation 
[AS]. In these genotypes the dibucaine 
number would be reduced to a value of 
10-30% inhibition of PsChE, and/or total 
PsChE activity would be low. However, 
there are numerous, but rare mutations 
of the butyrylcholinesterase gene, which 
are not tested within the routine clinical 
setting, for example the K variant which 
is identified only with DNA sequencing. 
(4) Another abnormal genotype is a 
fluoride resistant butyrylcholinesterase 
gene, i.e., the fluoride resistant PsChE 
variant (homozygous variant present in 
1/150.000). (5) Homozygous patients 
with the fluoride resistant gene would 
be expected to have a paralysis after 
succinylcholine which ranges from 1 to 
2 hours, (6) which correspond to mus-
cle paralysis encountered in our patient. 
In our institution, as is true for clinical 
institutions across the United States, 
testing for rare mutations in the butyryl-
cholinesterase gene is not performed. 
Therefore, we cannot comment on the 
exact etiology of the prolonged neu-
romuscular blockade to succinylcho-
line in our patient. Our patient did not 
have any other conditions which could 
lead to prolongation of succinylcholine 
action (certain tumors, use of medi-
cation such as timolol, cyclophosph-
amide, bambuterol, aminoglycosides, 
neostigmine). (6)  
In conclusion, we have described an 
unusual case of inability to monitor the 
RLN with EMG in a patient who was fully 
paralyzed after succinylcholine presu-
mably due to PsChE deficiency. In cases 
of unexplained inability to monitor the 
RLN, anesthesiologists should expand 
the differential diagnosis beyond the 
most typical malfunction faults (equi-
pment malfunction) and should evaluate 
potential for other rare conditions such 
as one described in our patient. 
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